UNLABELLED: The objectives of this study were 1) to examine whether the prevalence of 22q11.2 deletion syndrome (22q11DS) in schizophrenia patients with the Deficit syndrome is higher than the reported approximately 2% for the population of schizophrenia patients as a whole, and 2) to estimate the overall prevalence of 22q11DS among schizophrenia patients by combining all available studies. Our sample, enriched for patients with the Deficit syndrome, had 88% power to detect an estimated prevalence of 5% of 22q11.2 deletions. No 22q11.2 deletions were detected in 311 schizophrenia patients, 146 of whom met criteria for the Deficit syndrome. Our literature research revealed that in eight studies sixteen deletions were identified in 2133 patients with schizophrenia. This corresponds to a prevalence of 0.75% (95%CI: 0.5%-1.2%). IN CONCLUSION: The prevalence of 22q11.2DS in schizophrenia patients with the Deficit syndrome is not higher than in the population of schizophrenia patients as a whole. The prevalence of 22q11.2DS in schizophrenia patients is lower than the frequently reported prevalence of 2% or more.
UNLABELLED: The objectives of this study were 1) to examine whether the prevalence of 22q11.2 deletion syndrome (22q11DS) in schizophreniapatients with the Deficit syndrome is higher than the reported approximately 2% for the population of schizophreniapatients as a whole, and 2) to estimate the overall prevalence of 22q11DS among schizophreniapatients by combining all available studies. Our sample, enriched for patients with the Deficit syndrome, had 88% power to detect an estimated prevalence of 5% of 22q11.2 deletions. No 22q11.2 deletions were detected in 311 schizophreniapatients, 146 of whom met criteria for the Deficit syndrome. Our literature research revealed that in eight studies sixteen deletions were identified in 2133 patients with schizophrenia. This corresponds to a prevalence of 0.75% (95%CI: 0.5%-1.2%). IN CONCLUSION: The prevalence of 22q11.2DS in schizophreniapatients with the Deficit syndrome is not higher than in the population of schizophreniapatients as a whole. The prevalence of 22q11.2DS in schizophreniapatients is lower than the frequently reported prevalence of 2% or more.
Authors: S I Usiskin; R Nicolson; D M Krasnewich; W Yan; M Lenane; M Wudarsky; S D Hamburger; J L Rapoport Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-12 Impact factor: 8.829
Authors: Jacob A S Vorstman; Monique E J Morcus; Sasja N Duijff; Petra W J Klaassen; Josien A Heineman-de Boer; Frits A Beemer; Hanna Swaab; René S Kahn; Herman van Engeland Journal: J Am Acad Child Adolesc Psychiatry Date: 2006-09 Impact factor: 8.829
Authors: T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel Journal: Hum Mol Genet Date: 2000-03-01 Impact factor: 6.150
Authors: T Arinami; T Ohtsuki; K Takase; H Shimizu; T Yoshikawa; H Horigome; J Nakayama; M Toru Journal: Schizophr Res Date: 2001-12-01 Impact factor: 4.939
Authors: Hui Liu; Simon C Heath; Christina Sobin; J Louw Roos; Brandi L Galke; Maude L Blundell; Marge Lenane; Brian Robertson; Ellen M Wijsman; Judith L Rapoport; Joseph A Gogos; Maria Karayiorgou Journal: Proc Natl Acad Sci U S A Date: 2002-03-12 Impact factor: 11.205
Authors: Anne S Bassett; Gregory Costain; Wai Lun Alan Fung; Kathryn J Russell; Laura Pierce; Ronak Kapadia; Ronald F Carter; Eva W C Chow; Pamela J Forsythe Journal: J Psychiatr Res Date: 2010-11 Impact factor: 4.791
Authors: Jacob A S Vorstman; Eva W Chow; Roel A Ophoff; Herman van Engeland; Frits A Beemer; René S Kahn; Richard J Sinke; Anne S Bassett Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2009-04-05 Impact factor: 3.568
Authors: Jacobine E Buizer-Voskamp; Jan-Willem Muntjewerff; Eric Strengman; Chiara Sabatti; Hreinn Stefansson; Jacob A S Vorstman; Roel A Ophoff Journal: Biol Psychiatry Date: 2011-04-13 Impact factor: 13.382
Authors: K Ahn; N Gotay; T M Andersen; A A Anvari; P Gochman; Y Lee; S Sanders; S Guha; A Darvasi; J T Glessner; H Hakonarson; T Lencz; M W State; Y Y Shugart; J L Rapoport Journal: Mol Psychiatry Date: 2013-05-21 Impact factor: 15.992
Authors: Anna C Need; Dongliang Ge; Michael E Weale; Jessica Maia; Sheng Feng; Erin L Heinzen; Kevin V Shianna; Woohyun Yoon; Dalia Kasperaviciūte; Massimo Gennarelli; Warren J Strittmatter; Cristian Bonvicini; Giuseppe Rossi; Karu Jayathilake; Philip A Cola; Joseph P McEvoy; Richard S E Keefe; Elizabeth M C Fisher; Pamela L St Jean; Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Andreas Ruppert; Gillian Fraser; Caroline Crombie; Lefkos T Middleton; David St Clair; Allen D Roses; Pierandrea Muglia; Clyde Francks; Dan Rujescu; Herbert Y Meltzer; David B Goldstein Journal: PLoS Genet Date: 2009-02-06 Impact factor: 5.917